Feasibility and Safety of Outpatient Parenteral Antimicrobial Therapy in Conjunction With Addiction Treatment for People Who Inject Drugs

J Infect Dis. 2020 Sep 2;222(Suppl 5):S494-S498. doi: 10.1093/infdis/jiaa025.

Abstract

Background: Research is limited on combining outpatient parenteral antimicrobial therapy (OPAT) with addiction treatment for people who inject drugs (PWID) with serious infections.

Methods: This is a retrospective study of PWID (n = 68) requiring intravenous antibiotics evaluated for suitability for our OPAT program with concurrent addiction treatment.

Results: Most common infections were bacteremia and/or endocarditis (73.5%), bone and/or joint infections (32.4%), and epidural abscess (22.1%). Of the 20 patients (29.4%) who qualified, 100.0% completed the course of antibiotics, 30.0% experienced a 30-day readmission, and 15.0% relapsed. No overdoses, deaths, or peripherally inserted central catheter-line complications were reported.

Conclusions: Outpatient parenteral antimicrobial therapy with addiction treatment may be feasible and safe for PWID with serious infections.

Keywords: bacterial infections; injection drug use; opioid use disorder; outpatient parenteral therapy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Intravenous / adverse effects
  • Administration, Intravenous / instrumentation
  • Adult
  • Ambulatory Care / methods*
  • Ambulatory Care / statistics & numerical data
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / adverse effects
  • Bacteremia / drug therapy*
  • Bacteremia / microbiology
  • Bone Diseases, Infectious / drug therapy*
  • Bone Diseases, Infectious / microbiology
  • Central Venous Catheters / adverse effects
  • Endocarditis, Bacterial / drug therapy*
  • Endocarditis, Bacterial / microbiology
  • Feasibility Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Readmission / statistics & numerical data
  • Retrospective Studies
  • Substance Abuse, Intravenous / complications
  • Substance Abuse, Intravenous / therapy*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents